Research Article
HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
Table 4
Multivariate Cox proportional hazard regression analysis of HER-2 expression and clinicopathological parameters influence on patients overall survival.
| ||||||||||||||||||||||
aHercep test criteria modified by Hofmann et al. [16] for gastric cancer. bPercentage of HER-2-positive gastric cancer cells (%) according to Remmele et al. [15] modified by authors. cIntensity of immunohistochemical reaction in cancer cells (I) according to Remmele and Stegner [15] modified by authors. dIRS score (ImmunoReactive Score) according to Remmele and Stegner [15] modified by authors. |